1. Cohn L, Edmunds LH. Cardiac Surgery in the Adult. 2nd ed. New York: McGraw-Hill; 2003:xxiv, 1573 pp.
2. St. Andre AC
, DelRossi A. Hemodynamic management of patients in the first 24 hours after cardiac surgery. Crit Care Med.
3. London MJ, Moritz T, Henderson W, et al. Standard versus fiberoptic pulmonary artery catheterization for cardiac surgery in the Department of Veterans Affairs: a prospective, observational, multicenter analysis. Anesthesiology. 2002;96(4):860–870.
4. Polonen P, et al. A prospective, randomized study of goal-oriented hemodynamic therapy in cardiac surgical patients. Anesth Analg. 2000;90(5):1052–1059.
5. Boyd O, Grounds RM, Bennett ED. A randomized clinical trial of the effect of deliberate perioperative increase of oxygen
delivery on mortality in high-risk surgical patients. JAMA.
6. Yu M, et al. Effect of maximizing oxygen
delivery on morbidity and mortality rates in critically ill patients: a prospective, randomized, controlled study. Crit Care Med.
7. Gattinoni L, et al. A trial of goal-oriented hemodynamic therapy in critically ill patients. SvO2 Collaborative Group. N Engl J Med. 1995;333(16):1025–1032.
8. Ernest D, Belzberg AS, Dodek PM. Distribution of normal saline and 5% albumin
infusions in septic patients. Crit Care Med.
9. Gallagher JD, et al. Effects of colloid or crystalloid administration on pulmonary extravascular water in the postoperative period after coronary artery bypass grafting. Anesth Analg. 1985;64(8):753–758.
10. Fremes SE, et al. Effects of postoperative hypertension and its treatment. J Thorac Cardiovasc Surg. 1983; 86(1):47–56.
11. Feneck RO, et al. Comparison of the hemodynamic effects of milrinone
in patients after cardiac surgery. J Cardiothorac Vasc Anesth.
12. Kantrowitz A, et al. Initial clinical experience with intraaortic balloon pumping in cardiogenic shock. JAMA. 1968;203(2):113–118.
13. Samuels LE, et al. Pharmacological criteria for ventricular assist device insertion following postcardiotomy shock: experience with the Abiomed BVS system. J Card Surg. 1999;14(4):288–293.
14. Maisel WH, Rawn JD, Stevenson WG. Atrial fibrillation after cardiac surgery. Ann Intern Med. 2001;135(12): 1061–1073.
15. Rho RW. The management of atrial fibrillation after cardiac surgery. Heart. 2009;95(5):422–429.
16. Hein OV, et al. Three-year survival after four major post-cardiac operative complications. Crit Care Med. 2006;34(11):2729–2737.
17. Baggish AL, Sabatine MS. Clopidogrel
use in coronary artery disease. Expert Rev Cardiovasc Ther.
18. Gill R, et al. Safety and efficacy of recombinant activated factor VII: a randomized placebo-controlled trial in the setting of bleeding after cardiac surgery. Circulation. 2009;120(1):21–27.
19. Higgins TL. Safety issues regarding early extubation after coronary artery bypass surgery. J Cardiothorac Vasc Anesth. 1995;9(5 suppl 1):24–29.
20. Akhtar MI, Hamid M. Success and failure of fast track extubation in cardiac surgery patients of tertiary care hospital: one year audit. J Pak Med Assoc. 2009;59(3): 154–156.
21. Wong DT, et al. Risk factors of delayed extubation, prolonged length of stay in the intensive care unit, and mortality in patients undergoing coronary artery bypass graft with fast-track cardiac anesthesia: a new cardiac risk score. Anesthesiology. 1999;91(4):936–944.
22. Puntillo K, Weiss SJ. Pain: its mediators and associated morbidity in critically ill cardiovascular surgical patients. Nurs Res. 1994;43(1):31–36.
23. Gust R, et al. Effect of patient-controlled analgesia on pulmonary complications after coronary artery bypass grafting. Crit Care Med. 1999;27(10):2218–2223.
24. Jensen L, Yang L. Risk factors for postoperative pulmonary complications in coronary artery bypass graft surgery patients. Eur J Cardiovasc Nurs. 2007;6(3):241–246.
25. Wynne R, Botti M. Postoperative pulmonary dysfunction in adults after cardiac surgery with cardiopulmonary bypass: clinical significance and implications for practice. Am J Crit Care. 2004;13(5):384–393.
26. Maggart M, Stewart S. The mechanisms and management of noncardiogenic pulmonary edema following cardiopulmonary bypass. Ann Thorac Surg. 1987;43(2): 231–236.
27. Boyd JE, Bewman JH, Brigham KL. Permeability pulmonary edema. Diagnosis and management. Arch Intern Med. 1984;144(1):143–147.
28. Tonz M, et al. Acute lung injury during cardiopulmonary bypass. Are the neutrophils responsible? Chest. 1995;108(6):1551–1556.
29. Chenoweth DE, et al. Complement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxins. N Engl J Med. 1981;304(9): 497–503.
30. Royston D, et al. Increased production of peroxidation products associated with cardiac operations. Evidence for free radical generation. J Thorac Cardiovasc Surg. 1986;91(5):759–766.
31. Craddock PR, et al. Complement and leukocyte-mediated pulmonary dysfunction in hemodialysis. N Engl J Med. 1977;296(14):769–774.
32. Hammerschmidt DE, et al. Complement activation and neutropenia occurring during cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1981;81(3):370–377.
33. Allardyce DB, Yoshida SH, Ashmore PG. The importance of microembolism in the pathogenesis of organ dysfunction caused by prolonged use of the pump oxygenator. J Thorac Cardiovasc Surg. 1966;52(5):706–715.
34. Heidecker J, Sahn SA. The spectrum of pleural effusions after coronary artery bypass grafting surgery. Clin Chest Med. 2006;27(2):267–283.
35. Peng MJ, et al. Postoperative pleural changes after coronary revascularization. Comparison between saphenous vein and internal mammary artery grafting. Chest. 1992;101(2):327–330.
36. Gale GD, et al. Pulmonary atelectasis and other respiratory complications after cardiopulmonary bypass and investigation of aetiological factors. Can Anaesth Soc J. 1979;26(1):15–21.
37. Daganou M, et al. Respiratory complications after coronary artery bypass surgery with unilateral or bilateral internal mammary artery grafting. Chest. 1998;113(5): 1285–1289.
38. Hurlbut D, et al. Pleuropulmonary morbidity: internal thoracic artery versus saphenous vein graft. Ann Thorac Surg. 1990;50(6):959–964.
39. Rolla G, et al. Effect of pleurotomy on pulmonary function after coronary artery bypass grafting with internal mammary artery. Respir Med. 1994;88(6):417–420.
40. Labidi M, et al. Pleural effusions following cardiac surgery. Prevalence, risk factors, and clinical features. Chest. 2009;136:1604–1611.
41. Peng MC, et al. Prevalence of symptomatic large pleural effusions first diagnosed more than 30 days after coronary artery bypass graft surgery. Respirology. 2007;12(1): 122–126.
42. Hashim SW, et al. Noncardiogenic pulmonary edema after cardiopulmonary bypass. An anaphylactic reaction to fresh frozen plasma. Am J Surg. 1984;147(4):560–564.
43. Brooks JC. Noncardiogenic pulmonary edema immediately following rapid protamine
administration. Ann Pharmacother.
44. Frost L, et al. Prognosis and risk factors in acute, dialysis-requiring renal failure after open-heart surgery. Scand J Thorac Cardiovasc Surg. 1991;25(3):161–166.
45. MaWhinney S, et al. Identification of risk factors for increased cost, charges, and length of stay for cardiac patients. Ann Thorac Surg. 2000;70(3):702–710.
46. Suen WS, et al. Risk factors for development of acute renal failure (ARF) requiring dialysis in patients undergoing cardiac surgery. Angiology. 1998;49(10):789–800.
47. Lassnigg A, et al. Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study. J Am Soc Nephrol. 2004;15(6):1597–1605.
48. Swaminathan M, et al. Trends in acute renal failure associated with coronary artery bypass graft surgery in the United States. Crit Care Med. 2007;35(10):2286–2291.
49. Feindt PR, et al. Effects of high-dose aprotinin on renal function in aortocoronary bypass grafting. Ann Thorac Surg. 1995;60(4):1076–1080.
50. Kuitunen A, et al. Acute renal failure after cardiac surgery: evaluation of the RIFLE classification. Ann Thorac Surg. 2006;81(2):542–546.
51. Bellomo R, et al. Acute renal failure—definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004;8(4):R204–R212.
52. Hoste EA, et al. RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis. Crit Care. 2006;10(3):R73.
53. Bove T, et al. Renoprotective action of fenoldopam
in high-risk patients undergoing cardiac surgery: a prospective, double-blind, randomized clinical trial. Circulation.
54. Sisillo E, et al. N-Acetylcysteine for prevention of acute renal failure in patients with chronic renal insufficiency undergoing cardiac surgery: a prospective, randomized, clinical trial. Crit Care Med. 2008;36(1):81–86.
55. Barr LF, Kolodner K. N
-Acetylcysteine and fenoldopam
protect the renal function of patients with chronic renal insufficiency undergoing cardiac surgery. Crit Care Med.
56. Ryckwaert F, et al. Incidence, risk factors, and prognosis of a moderate increase in plasma creatinine early after cardiac surgery. Crit Care Med. 2002;30(7):1495–1498.
57. Callahan M, et al. Economic consequences of renal dysfunction among cardiopulmonary bypass surgery patients: a hospital-based perspective. Value Health. 2003;6(2):137–143.
58. Rocktaeschel J, et al. Acid–base status of critically ill patients with acute renal failure: analysis based on Stewart–Figge methodology. Crit Care. 2003;7(4):R60.
59. Kellum JA, Song M, Li J. Lactic and hydrochloric acids induce different patterns of inflammatory response in LPS-stimulated RAW 264.7 cells. Am J Physiol Regul Integr Comp Physiol. 2004;286(4):R686–R692.
60. Thakar CV, et al. Renal dysfunction and serious infections after open-heart surgery. Kidney Int. 2003;64(1): 239–246.
61. Kramer AA, et al. Renal ischemia/reperfusion leads to macrophage-mediated increase in pulmonary vascular permeability. Kidney Int. 1999;55(6):2362–2367.
62. Donnahoo KK, et al. Review article: the role of tumor necrosis factor in renal ischemia–reperfusion injury. J Urol. 1999;162(1):196–203.
63. Egleston CV, et al. Gastrointestinal complications after cardiac surgery. Ann R Coll Surg Engl. 1993;75(1):52–56.
64. Mangi AA, et al. Gastrointestinal complications in patients undergoing heart operation: an analysis of 8709 consecutive cardiac surgical patients. Ann Surg. 2005;241(6):895–901. Discussion 901–904.
65. Ohri SK, et al. Intraabdominal complications after cardiopulmonary bypass. Ann Thorac Surg. 1991;52(4): 826–831.
66. Krasna MJ, et al. Gastrointestinal complications after cardiac surgery. Surgery. 1988;104(4):773–780.
67. Leitman IM, et al. Intra-abdominal complications of cardiopulmonary bypass operations. Surg Gynecol Obstet. 1987;165(3):251–254.
68. Lazar HL, et al. Gastrointestinal complications following cardiac surgery. Cardiovasc Surg. 1995;3(3):341–344.
69. Zacharias A, et al. Predictors of gastrointestinal complications in cardiac surgery. Tex Heart Inst J. 2000;27(2): 93–99.
70. Yilmaz AT, et al. Gastrointestinal complications after cardiac surgery. Eur J Cardiothorac Surg. 1996;10(9): 763–767.
71. Johnston G, et al. Changing perspective on gastrointestinal complications in patients undergoing cardiac surgery. Am J Surg. 1992;163(5):525–529.
72. Christenson JT, et al. Postoperative visceral hypotension the common cause for gastrointestinal complications after cardiac surgery. Thorac Cardiovasc Surg. 1994;42(3):152–157.
73. Baue AE. The role of the gut in the development of multiple organ dysfunction in cardiothoracic patients. Ann Thorac Surg. 1993;55(4):822–829.
74. Berger MM, et al. Intestinal absorption in patients after cardiac surgery. Crit Care Med. 2000;28(7):2217–2223.
75. Arrowsmith JE, Grocott HP, Newman MF. Neurologic risk assessment, monitoring and outcome in cardiac surgery. J Cardiothorac Vasc Anesth. 1999;13(6):736–743.
76. Svensson LG, Nadolny EM, Kimmel WA. Multimodal protocol influence on stroke and neurocognitive deficit prevention after ascending/arch aortic operations. Ann Thorac Surg. 2002;74(6):2040–2046.
77. Hogue CW Jr, et al. Sex differences in neurological outcomes and mortality after cardiac surgery: a Society of Thoracic Surgery National Database report. Circulation. 2001;103(17):2133–2137.
78. Roach GW, et al. Adverse cerebral outcomes after coronary bypass surgery. Multicenter study of Perioperative Ischemia Research Group and the Ischemia Research and Education Foundation Investigators. N Engl J Med. 1996;335(25):1857–1863.
79. Grega MA, Borowicz LM, Baumgartner WA. Impact of single clamp versus double clamp technique on neurologic outcome. Ann Thorac Surg. 2003;75(5):1387–1391.
80. Hammon JW, et al. Single crossclamp improves 6-month cognitive outcome in high-risk coronary bypass patients: the effect of reduced aortic manipulation. J Thorac Cardiovasc Surg. 2006;131(1):114–121.
81. Kolkka R, Hilberman M. Neurologic dysfunction following cardiac operation with low-flow, low-pressure cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1980;79(3):432–437.
82. Cohn LH, Edmunds LH. Cardiac Surgery in the Adult. 3rd ed. New York: McGraw-Hill Medical; 2008:xx, 1704 pp.
83. Boeken U, et al. Neurological complications after cardiac surgery: risk factors and correlation to the surgical procedure. Thorac Cardiovasc Surg. 2005;53(1):33–36.
84. Selnes OA, et al. Cognitive changes with coronary artery disease: a prospective study of coronary artery bypass graft patients and nonsurgical controls. Ann Thorac Surg. 2003;75(5):1377–1384. Discussion 1384–1386.
85. Selnes OA, et al. Cognitive outcomes three years after coronary artery bypass surgery: a comparison of on-pump coronary artery bypass graft surgery and nonsurgical controls. Ann Thorac Surg. 2005;79(4): 1201–1209.
86. Jensen BO, et al. Cognitive outcomes in elderly high-risk patients after off-pump versus conventional coronary artery bypass grafting: a randomized trial. Circulation. 2006;113(24):2790–2795.
87. Grey NJ, Perdrizet GA. Reduction of nosocomial infections in the surgical intensive-care unit by strict glycemic control. Endocr Pract. 2004;10 (suppl 2):46–52.
88. Goldberg PA, et al. Improving glycemic control in the cardiothoracic intensive care unit: clinical experience in two hospital settings. J Cardiothorac Vasc Anesth. 2004;18(6):690–697.
89. van den Berghe G, et al. Intensive insulin
therapy in the critically ill patients. N Engl J Med.
90. Arabi YM, et al. Intensive versus conventional insulin
therapy: a randomized controlled trial in medical and surgical critically ill patients. Crit Care Med.
91. Arabi YM, Tamim HM, Rishu AH. Hypoglycemia with intensive insulin
therapy in critically ill patients: predisposing factors and association with mortality. Crit Care Med.
92. Finfer S, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360(13):1283–1297.